Skip to search formSkip to main contentSkip to account menu

Concomitant Therapy

Known as: CONTRT 
Any pharmaceutical agent, other than the primary therapy, that is administered to or used by the subject prior to or during a specified time period.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis.
Background/Aims In Korea, increasing clarithromycin resistance has led to the need for an alternative first-line therapy for the… 
Review
2018
Review
2018
한국에서 헬리코박터 파일로리 감염에 대한 동시 치료와 순차 치료의 비교: 체계적 문헌고찰과 메타분석
Background/Aims: In Korea, increasing clarithromycin resistance has led to the need for an alternative first-line therapy for the… 
2017
2017
The first-line regimens of Helicobacter pylori eradication in Korea
Approximately half of the world’s population is infected by Helicobacter pylori [1], which causes various gastrointestinal… 
2017
2017
Response to Georgopoulos et al.
in Figure 1, which also attempts to refl ect this hierarchy. Th e above comments are also relevant to the authors concerns… 
Highly Cited
2016
Highly Cited
2016
[177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer].
Radioligand therapy (RLT) using 177Lu labelled inhibitors of the prostate-specific membrane antigen (177Lu-PSMA) is performed in… 
Review
2014
Review
2014
[New therapeutic strategies against Helicobacter pylori].
The standard therapy for Helicobacter pylori infection in Korea is a triple-drug regimen consisting of a proton pump inhibitor… 
2005
2005
Línea primaria en 22.9 kv de la central hidroeléctrica de Pacarenca a la Cia. Minera Haullanca (Pucarrajo)
2002
2002
Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics
Abstract: The aim of the study was to evaluate the efficacy and safety of disease-modifying drugs (DMARDs) in everyday clinical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)